Massmedica S.A. (WSE:MSM)
Poland flag Poland · Delayed Price · Currency is PLN
4.060
-0.080 (-1.93%)
At close: Jul 3, 2025

Massmedica Company Description

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases and regenerative medicines in Poland.

It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools for home treatments, and intra-articular injections for regeneration of the knee joints.

It also provides reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon ligaments; AdipSculpt, a fat graft collection and preparation kit for controlling vacuum during liposuction; and Ejal40, a locally acting non-surgical medical treatment that delivers regenerating or nourishing nutrients directly to the dermis.

The company offers its products to public and private hospitals. Massmedica S.A. was founded in 2011 and is headquartered in Warsaw, Poland.

Massmedica S.A.
Country Poland
Founded 2011
Industry Medical, Dental, and Hospital Equipment and Supplies
Employees 17
CEO Marek Mlodzianowski

Contact Details

Address:
ul. Adama Branickiego 17
Warsaw, 02-972
Poland
Phone 48 22 611 3960
Website massmedica.com

Stock Details

Ticker Symbol MSM
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
SIC Code 5047

Key Executives

Name Position
Marek Mlodzianowski Chief Executive Officer